Slaughter and May and Freshfields Bruckhaus Deringer are among four firms to have taken roles on the demerger of Reckitt Benckiser's pharmaceutical business.
November 18, 2014 at 07:11 PM
1 minute read
The original version of this story was published on Legalweek
Slaughter and May and Freshfields Bruckhaus Deringer are among four firms to have taken roles on the demerger of Reckitt Benckiser’s pharmaceutical business.
Slaughters corporate partners Rebecca Cousin and Jeff Twentyman are leading for Reckitt and Indivior, the company’s addiction control-focused pharma division, which will be demerged from the FTSE 100 group once shareholder approval is granted in December.
Presented by BigVoodoo
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
The African Legal Awards recognise exceptional achievement within Africa s legal community during a period of rapid change.
The premier educational and networking event for employee benefits brokers and agents.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
